Immune checkpoint inhibitors have been reported to cause various intestinal and gastrointestinal issues, including pseudo-obstruction, colitis, and enteritis. These immune-related adverse events can be severe and may involve multiple organs. The management and toxicity of these events are being studied and reported on, with some outlets discussing specific cases and others reviewing broader trends and guidelines for treatment.